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KAWALAN ADRENERGIK KE ATAS HEMODINAMIK GINJAL DALAM 
PELBAGAI KEADAAN PATOFISIOLOGI DENGAN KECACATAN GINJAL: 
PERANAN α1-ADRENOSEPTOR SUBJENIS 
 
 
ABSTRAK 
 
Kajian ini menyelidik samada berlaku sebarang perubahan dalam populasi α1-
adrenoseptor berfungsi dalam mengawalatur vasokonstriksi ginjal diaruh secara 
adrenergik di dalam model-model haiwan berpenyakit dengan kecacatan ginjal. 
Keadaan-keadaan patologikal ini termasuk kegagalan ginjal akut, gabungan kegagalan 
ginjal akut dengan hipertensi, dan nefropati diabetis awal. Juga, usaha dibuat untuk 
mengenalpasti α1-adrenoseptor subjenis berfungsi yang terlibat di dalam mengawalatur 
hemodinamik ginjal di dalam keadaan-keadaan penyakit ini.  Tikus jantan Wistar Kyoto 
(WKY) dan Spontaneously Hypertensive Rats (SHR) dengan berat 250-300g telah 
disuntik cisplatin (5 mg/kg i.p.) atau streptozotosin (55 mg/kg i.p.) dan diaruh dengan 
kegagalan ginjal akut atau nefropati diabetis awal. Dalam kumpulan kegagalan ginjal, 7 
hari kemudian, tikus-tikus ini dibius (natrium pentobarbiton, 60 mg/kg i.p.) dan kajian 
hemodinamik dijalankan. Manakala, di dalam tikus dengan nefropati diabetis awal, 
kajian hemodinamik dijalankan selepas 4 minggu diberi streptozotosin. Dalam kajian 
hemodinamik, perubahan dalam pengaliran darah ginjal disebabkan rangsangan saraf 
elektrikal dan pemberian noradrenalin, fenilefrin dan metoksamin secara intra ginjal 
tertutup ditentukan sebelum dan selepas penggunaan amlodipin, 5-metilurapidil, 
kloroetilklonidin dan BMY7378.  Dalam kegagalan ginjal dan nefropati diabetis awal, 
ketidakcekapan ginjal disahkan dan ditentukan dengan perubahan fisiologi, iaitu jumlah 
air diminum dalam 24j, jumlah kencing dalam 24j dan berat badan. Di samping itu, 
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beberapa parameter fungsi, iaitu penyingkiran kreatinin, pengkumuhan terpecah 
natrium, kadar penapisan glomerulus, indeks ginjal dan pemerhatian histologi juga 
diambilkira. Tikus dengan kegagalan ginjal mempunyai ciri-ciri oligourea, penyingkiran 
kreatinin yang rendah, indeks ginjal yang tinggi, pengkumuhan terpecah natrium yang 
meningkat dan kadar penapisan glomerular yang berkurangan (kesemua p<0.05). 
Selain perubahan-perubahan ini, tikus dengan nefropati diabetis awal juga 
menunjukkan pengaliran darah ginjal yang berkurangan (p<0.05). Di dalam tikus 
dengan kegagalan ginjal dan nefropati diabetis awal, respon vasokonstriktor ginjal 
kepada aruhan secara adrenergik (RNS, NA, PE, ME) dipengaruhi secara signifikan 
(p<0.05) oleh kesemua antagonis adrenergik. Secara umum, AMP, MEU dan BMY 
7378 secara signifikan merencat respon vasokonstriktor ginjal di dalam kesemua 
kumpulan ujikaji (kesemua p<0.05). Bagaimanapun, di dalam kumpulan kajian fungsi 
normal ginjal, CEC tidak mempengaruhi (kesemua p>0.05) vasokonstriksi ginjal teraruh 
adrenergik (RNS, NA, PE and ME).  Keputusan yang diperolehi dari kajian ini 
menunjukkan dengan jelas kehadiran α1-adrenoseptor subjenis yang pelbagai dalam 
pengawalaturan respon vasokonstriktor ginjal teraruh adrenergik di dalam saluran 
darah ginjal tikus dengan atau tanpa kecacatan ginjal. Kajian ini juga menunjukkan 
yang α1-adrenoseptor yang terlibat ialah α1A- dan α1D-subjenis. Oleh itu, keputusan-
keputusan ini menunjukkan tiada sebarang keadaan patologikal yang digunakan dalam 
kajian ini menyebabkan perubahan besar di dalam populasi α1-adrenoseptor subjenis 
ginjal berfungsi. Keputusan kami, walaubagaimanapun, buat pertama kalinya 
melaporkan dengan yakin akan α1-adrenoseptor subjenis berfungsi di dalam saluran 
darah ginjal dengan pelbagai bentuk kecacatan ginjal. Adalah juga dicadangkan di 
dalam saluran darah ginjal tikus dengan kecacatan ginjal, selain dari α1A- dan α1B-
adrenoseptor subjenis, kemungkinan ada jenis-jenis lain α1-adrenoseptor subjenis atau 
α2-adrenoseptor yang memainkan peranan. Keputusan-keputusan ini menunjukkan 
satu kemungkinan penglibatan α1B-adrenoseptor subjenis di lokasi pre- dan pasca-
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sinaptik pada saluran darah ginjal tikus dengan kecacatan ginjal. Juga, di dalam tikus 
dengan kecacatan ginjal, wujud satu interaksi yang kompleks dan juga satu 
perhubungan di kalangan α1-adrenoseptor subjenis pada tahap saluran darah 
berintangan ginjal di dalam pengawalaturan respon vasokonstriktor ginjal teraruh 
adrenergik.  
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ADRENERGIC CONTROL OF RENAL HEMODYNAMICS IN DIFFERENT 
PATHOPHYSIOLOGICAL STATES WITH RENAL IMPAIRMENT: THE ROLE OF 
α1-ADRENOCEPTOR SUBTYPES 
 
 
ABSTRACT 
 
This study investigated whether there is any alteration in the functional 
population of α1-adrenoceptors in mediating adrenergically induced renal 
vasoconstrictions in animal models of some pathological states characterized with 
renal impairment.  These pathological states include acute renal failure, combined 
state of acute renal failure and hypertension and experimental early diabetic 
nephropathy.  Further, attempts were made to characterize the functional α1-
adrenoceptor subtypes involved in modulating renal hemodynamics in these 
pathological states.  Male Wistar Kyoto (WKY) and Spontaneously Hypertensive 
Rats (SHR) weighing 250-300g were given either cisplatin (5 mg/kg i.p.) or 
streptozotocin (55 mg/kg i.p.) to induce with acute renal failure and experimental 
early diabetic nephropathy, respectively.  In renal failure groups, seven days later 
the rats were anesthetized (sodium pentobarbitone, 60 mg/kg i.p.) and 
hemodynamic studies were conducted.  While, in the rats with experimental early 
diabetic nephropathy the hemodynamic studies were carried out four weeks post 
streptozotocin.  In the hemodynamic studies, the changes in the renal blood flow 
(RBF) caused by the electrical stimulation of renal nerves (RNS) and close 
intrarenal administration of noradrenaline (NA), phenylephrine (PE) and 
methoxamine (ME) were determined before and after amlodipine (AMP), 5-
methylurapidil (MEU), chloroethylclonidine (CEC) and BMY 7378.  In renal failure 
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and experimental early diabetic nephropathy rats, the renal insufficiencies were 
confirmed and characterized by physiological changes viz. 24h water intake, 24h 
urine output and body weight.  Further, several renal functional parameters viz. 
creatinine clearance, fractional excretion of sodium, glomerular filtration rate, kidney 
index and histological observations were also considered in this respect.  The renal 
failure rats were characterized with marked oligourea, severely reduced creatinine 
clearance, increased kidney index, increased fractional excretion of sodium, 
reduced glomerular filtration rate and severe reduction of renal blood flow (all 
p<0.05).  While the early diabetic nephropathy rats had severe polyurea, 
hyperglycemia, moderately decreased creatinine clearance, increased kidney 
index, fractional excretion of sodium and glomerular filtration rate (all p<0.05).  
Beside these changes, the early diabetic nephropathy animals also had reduced 
renal blood flow (p<0.05).  In renal failure and early diabetic nephropathy rats, the 
adrenergically (RNS, NA, PE, ME) induced renal vasoconstrictor responses were 
significantly (all p<0.05) influenced by all the adrenergic antagonists.  In general, 
AMP, MEU and BMY 7378 significantly attenuated the renal vasoconstrictor 
responses in all experimental groups (all p<0.05).  CEC showed interesting and 
varied responses in the rats with renal impairment and these responses were either 
attenuation or accentuation of the adrenergically induced renal vasoconstrictor 
responses (all p<0.05).  However, in the experimental groups with normal renal 
functions CEC did not influence the adrenergically induced (RNS, NA, PE and ME) 
renal vasoconstrictions (all p>0.05).  The results derived in this study clearly 
indicated the presence of multiple functional α1-adrenoceptor subtypes in mediating 
the adrenergically induced renal vasoconstrictor responses in the renal vasculature 
of the rats with or without renal impairment.  This study also showed that these α1-
adrenoceptors were of α1A– and α1D–subtypes.  Hence, the results obtained 
indicated that none of the pathological states used in this study caused any major 
 xxix
shift in the functional population of renal α1–adrenoceptor subtypes.  Our results, 
however, for the first time convincingly reported the functional subtypes of α1–
adrenoceptor in the renal vasculature of rats with different forms of renal 
impairments.  It was further suggested that in the renal vasculature of rats with 
renal impairment, apart from α1A- and α1D-adrenoceptor subtypes, there could be 
other α1-adrenoceptor subtypes and even the α2-adrenoceptors that might play a 
potential functional role.  The results obtained particularly indicated a possible 
functional involvement of α1B-adrenoceptor subtypes both at the pre- and post-
synaptic sites in the renal vasculature of rats with renal impairment.  Furthermore, 
in the rats with renal impairment there was a complex interaction and also a cross-
talk relationship between the α1-adrenoceptor subtypes at the level of renal 
resistance vessel in modulating adrenergically induced renal vasoconstrictor 
responses. 
 
CHAPTER ONE 
 
 
 
INTRODUCTION 
 
 
1.1 The Kidney 
 
1.1.1 Basic anatomy 
The kidneys are the primary organs of the urinary system and essential for life.  
A cell’s function depends not merely upon receiving a continuous supply of nutrients 
and eliminating its metabolic end products but also upon the existence of stable 
physicochemical conditions in the extra-cellular fluids bathing it or the “internal 
environment” as mentioned by Claude Bernard’s.  Maintenance of such stability is the 
most important function of the kidneys (Vander, 1980). 
 
The kidneys ensure that the body is in a homeostatic balance of fluids and ions 
essential for most intra- and extra-cellular physiological functions.  The kidney 
processes the plasma portion of the blood by removing the substances from it and in 
some instances by adding some substances to it.  In this effort, they carry out an array 
of functions.  The most important function that kidney plays is the essential role in the 
regulation of water concentration, inorganic-ion composition and volume of the internal 
environment.  The kidneys excrete the metabolic waste products into the urine as fast 
as they are produced in the body.  The kidney also plays an important role in the 
excretion of xenobiotics (drugs, pesticide, food additives and their metabolites etc.) in 
urine.  Moreover, the kidneys regulate the level at which the blood pressure is set by 
means of secreting renin and thus act as an endocrine gland.  Being an endocrine 
gland they are also involved in the synthesis of humoral agents including                
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1,25-dihydroxyvitamin D, erythropoietin etc.  The kidneys also play a pivotal role in the 
maintenance of blood pressure by virtue of their ability to regulate blood volume and 
salt excretion.  Indeed, there is a well-accepted notion that persistently elevated blood 
pressure can be resulted due to an inappropriately functioning kidney (Vander, 1980; 
Sattar, 1994; Applegate, 2000; Vander et al., 2001). 
 
Anatomically, the paired kidneys are located between the 12th thoracic and 3rd 
lumbar vertebrae, one on each side of the vertebral column.  They are located just 
above the waist between the parietal peritoneum and the posterior wall of the abdomen 
and hence are known as retroperitoneal organ.  In adults, each kidney is about 12 cm 
long, 6 cm wide and 3 cm thick.  It is roughly a bean-shaped organ with indentation on 
the medial side called hilum.  At the hilum, the renal veins leave while the renal arteries 
enter into the kidney.  A frontal section of the kidney shows that it is made of renal 
cortex and medulla.  The cortex and medulla make up the renal parenchyma, which is 
the functional tissue of the kidney (Applegate, 2000; Vander et al., 2001).  
 
The functional unit of the kidney is nephron.  Each kidney consists of over a 
million of such units in the renal parenchyma.  Each nephron is made up of two parts, 
an initial filtering component known as renal corpuscle and renal tubules that extend 
out from the renal corpuscle.  The renal corpuscle consists of a cluster of capillaries 
known as glomerulus encapsulated by a double-layered epithelial cup, the glomerular 
capsule and function as an ultrafilter through which a considerable quantity of cell-free 
and almost protein free fluid is filtered from the plasma.  The renal corpuscles are 
continuous with the renal tubules that carry fluid away from the glomerular capsules 
and mainly consist of proximal convoluted tubule, loops of Henlé and distal convoluted 
tubules (Vander, 1980, 1995; Applegate, 2000; Vander et al., 2001). 
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1.1.1.1 The glomerulus 
The glomerulus consists of a compact tuft of glomerular capillaries and a 
balloon like fluid-filled capsule know as Bowman’s capsule into which this tuft of 
glomerular capillaries protrudes.  The combination of glomerulus and Bowman’s 
capsule constitute the renal corpuscle.  Each glomerulus is supplied with blood by an 
afferent arteriole and as blood flows through the glomerulus, a portion of the plasma 
filters into the Bowman’s capsule.  The remaining blood then leaves the glomerulus by 
the efferent arteriole.  The blood in the glomerulus is separated from the fluid in the 
Bowman’s space (the space exists within the capsule) by a filtration barrier that 
consists of three layers: capillary endothelium, basement membrane and a single 
celled layer made of capsular epithelial cells.  The functional importance of this 
anatomical arrangement is that the blood, which flows through the glomerular capillary 
is separated from the Bowman’s space by a set of membranes already mentioned.  
The filtered fluid then flows to the site where Bowman’s capsule is joined at the side 
which is opposite of the glomerular tuft and attached with the first portion of the tubules 
(Vander, 1980, 1995; Vander et al., 2001). 
 
1.1.1.2 The juxtaglomerular apparatus 
The ascending limb of the loop of Henlé comes into contact with the glomerular 
afferent arterioles of the same nephron in a region where it continues into distal 
convoluted tubule.  In this region of contact the macula densa is formed from the 
modified cells of the ascending limb whereas juxtaglomerular cells are formed from 
those in the afferent arterioles.  The macula densa and juxtaglomerular cells together 
form the juxtaglomerular apparatus (Vander, 1980; Applegate, 2000). 
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1.1.1.3 The tubules  
The renal tubule is continuous with the Bowman’s capsule and is a narrow 
hollow cylinder made of a single layer of epithelial cells.  The epithelial cells of the 
tubule differ in structure and function along the tubule’s length and 10 to 12 different 
segments have been recognized so far.  The renal tubule consists mainly of three 
regions, proximal convoluted tubule, loop of Henlé and distal convoluted tubule. 
Considering the scope of this thesis we will not discuss all these regions in detail, 
rather a brief description of each will be presented. 
 
Proximal tubule 
The segment of the tubule that drains Bowman’s capsule is known as proximal 
tubule.  It comprises of the proximal convoluted tubule and the proximal straight tubule.  
These two parts of proximal tubule differ from each other structurally and functional 
heterogeneity may also exist.  In the proximal tubule, variation in terms of morphology 
is believed to exist in human and animal.  In human, it is observed that the proximal 
tubule is comprised of the convoluted and the straight portions (Guyton and Hall, 
1996).  In the rat, rabbit and monkey the proximal tubule consist of three different 
segments (Maunsbach, 1973; Guyton and Hall, 1996).  The first segment is the initial 
portion of the convoluted tubule (S1), the terminal portion of the pars convulata and the 
first part of the pars recta made the second segment (S2) while the remainder of the 
pars recta before its transition into the thin descending limb of the loop of Henlé makes 
the third segment (S3).  Structure of the brush border, the number and size of 
mitochondria, basolateral invagination and lysosomes distinguished three segments of 
proximal tubule (Guyton and Hall, 1996).   
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Loop of Henlé 
Following the proximal tubule is a sharp hairpin-like structure known as loop of 
Henlé, made of a descending limb, straighten from the proximal tubule and an 
ascending limb leading to distal convoluted tubule.  The descending limb is quite thin 
throughout its entire length.  On the other hand, the ascending limb remains thin in the 
first portion of a long loop and then becomes thick in the upper portion.  However, in 
the short loop the entire ascending limb is thick.  
 
The distal tubule 
Three morphologically distinct segments form the distal tubule, the thick 
ascending limb of loop of Henlé, the macula densa and the distal convoluted tubule.  At 
the end of the ascending limb of Henlé’s loop, the tubule passes between the arterioles 
supplying its glomerulus of origin and this particular segment is known as macula 
densa.  The tubule again becomes coiled just ahead of the macula densa and known 
as distal convoluted tubule.  The distal convoluted tubule on returning to the glomerulus 
of origin makes a short marginal contact with the afferent arteriole just before it enters 
into the Bowman’s capsule (Vander, 1980, 1995). 
 
The collecting ducts 
Urine passes from the nephron into the collecting duct system.  In relation to the 
other part of the renal tubule, fluids from the distal convoluted tubule flows into the 
collecting tubule.  The first part of this collecting duct is the connecting tubule, which is 
followed by the cortical and then the medullary collecting ducts.  Each of the over one 
million nephron, from the glomerulus to the collecting duct system is completely 
separated from each other.  In fact, multiple initial collecting tubules from separate 
nephron join to form cortical collecting duct which then turn downward into the medulla 
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and form the medullary collecting duct.  They finally drain urine into the kidney’s central 
cavity known as renal pelvis which is continuous with the ureter draining the kidney 
(Vander, 1980; Applegate, 2000; Vander et al., 2001). 
 
1.1.2 Renal hemodynamics 
The total blood flow to the kidneys in a typical adult is approximately 1.1 L/min. 
Remarkably, although the combined weight of both kidneys is less than 1% of the total 
body weight, the kidneys receive almost 20-25% of total cardiac output (5 L/min) i.e. 
almost 1.1 -1.2 L/minute (Guyton, 1989; Ganong, 1999; Applegate, 2000).  
 
The kidneys are highly vascularized organs abundantly supplied with blood 
vessels.  The right and left renal arteries carry the 20-25% of the resting cardiac output 
to the kidney.  The renal artery typically divides into a larger anterior branch and a 
comparatively smaller posterior branch just before or immediately after entering into the 
hilus of the kidney.  Several segmental arteries, each supplying a particular segment of 
the kidney originates from these branches.  These segmental arteries are further 
subdivided into branches and those that enter into the renal parenchyma between the 
renal pyramids in renal column are known as interlobar arteries.  These interlobar 
arteries arch between the cortex and medulla at the bases of the pyramids and are 
known as arcuate arteries.  The renal arcuate arteries give off branches known as 
interlobular arteries that extend into the cortex and give rise to the afferent arterioles 
(Guyton, 1989; Guyton and Hall, 1996; Ganong, 1999; Applegate, 2000). 
 
The blood passes through the capillaries in the glomerulus of the renal 
corpuscle from these afferent arterioles and then from the glomerular capillaries into 
the efferent arterioles.  Each renal corpuscle receives one afferent arteriole which 
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divides into the tangled capillary network know as glomerulus and these glomerular 
capillaries then reunite to form efferent arteriole.  Each efferent arteriole of a cortical 
nephron divides to form an extensive capillary network known as peritubular capillaries 
around the tubular portion (proximal and distal convoluted tubules) of the nephron.  The 
peritubular capillaries also form from the efferent arterioles of juxtamedullary nephron.  
The efferent arterioles also form long loop-shaped vessels known as vasa recta or the 
hairpin loop.  These loops deep down into the medulla alongside the loop of Henlé.  To 
supply a number of different nephron, the efferent arterioles from each glomerulus 
break up into the capillaries (Guyton, 1989; Ganong, 1999; Applegate, 2000).  The 
peritubular capillaries reunite to form peritubular venules and then interlobular veins. 
The interlobular veins also receive blood from the vasa recta.  The blood then drains 
through the arcuate veins to the interlobular veins running between the pyramids and 
the segmental veins and then into the renal veins that exist at the hilus of the kidney. 
The renal veins return the blood into the inferior vena cava (Applegate, 2000; Ganong, 
1999; Guyton, 1989).  
 
The blood flow through the kidneys distributed into large number of vascular 
channels arranged in parallel circuits, each supplied with similar perfusion pressure.  
The local blood flow is controlled by the vascular resistance of each channel and may 
therefore show disproportionate changes in various regions of the kidney (Auckland, 
1980).  The microvessels of each kidney also have the ability to autoregulate the renal 
blood flow.  The intrarenal blood flow distribution is very important for renal functions 
and hence alterations in the regional blood flow distribution may cause changes in the 
renal function (Regan et al., 1995).  The nerve supply to the kidney derives from the 
renal plexus of the sympathetic nervous system and accompanies the renal artery and 
their branches and is distributed to the blood vessels.  They control the blood flow 
through the kidney by regulating the diameter of the arterioles (Guyton, 1989; Ganong, 
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1999; Applegate, 2000).  The sequence of blood flow through the kidney is depicted in 
the Figure 1.1. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: The blood flow through the kidney goes in the sequence of the following 
order (Adapted from Ganong, 1999; Applegate, 2000) 
 
1.1.2.1 Factors influencing renal hemodynamics 
The renal blood flow is controlled by a number of physical and humoral factors 
and these factors are either intrinsic or extrinsic to the kidney.  The major intrinsic 
factors involved in the control of renal blood flow include autoregulatory mechanism, 
intrarenal renin-angiotensin mechanism, eicosanoids and kinins.  The extrinsic factors 
involved in the regulation of renal blood flow that includes the sympathetic nervous 
system, angiotensin II, antidiuretic hormones, dopamine and histamine.  Beside these, 
there are some other factors that play important role in causing changes in the renal 
hemodynamics.  These include endothelin, nitric oxide (NO), and atrial natriuretic 
Aorta Renal artery Interlobar artery
Arcuate artery Interlobular artery Afferent arteriole
Glomerulus Efferent arterioles Peritubular 
Interlobular vein Arcuate vein Interlobar vein
Segmental vein Renal vein Inferior vena cava
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peptide (ANP) (Vander, 1995; Unwin and Capasso, 2000; Koeppen and Stanton, 2001; 
Osborn et al., 2001; Paul and Ploth, 2001). 
 
1.1.2.1.1 Intrinsic factor 
 
Autoregulation 
The renal circulation markedly manifests the phenomenon of autoregulation.  
The autoregulation is an intrarenal system that maintains a constant renal blood flow 
(RBF) despite a fluctuation of mean arterial pressure (MAP) of about 80-180 mmHg.  
However, the autoregulation will become dysfunctional if the change in MAP is out of 
this range (Vander, 1980, 1995).  In the autoregulation phenomenon two mechanisms 
i.e. the myogenic and tubuloglomerular feedback mechanisms are involved.  The 
myogenic mechanism is solely based on the functions of baroreceptors or stretch 
receptors in the afferent arterioles.  In the face of increased MAP, the baroreceptors 
respond to the increased vascular wall tension and cause increased constriction of 
afferent arterioles.  This constriction prevents transmission of the increased arterial 
pressure to the glomerulus, hence, maintain the glomerular capillary pressure and 
glomerular filtration rate (Guyton, 1989; Vander, 1995).  In the event of a fall in the 
MAP, dilation of afferent arterioles occurs to allow for increased blood flow and 
maintenance of a normal glomerular capillary pressure and glomerular filtration rate. 
The myogenic mechanism of autoregulatory phenomenon may also be influenced by 
the increase and decrease in the amount of oxygen and other nutrients (Vander, 1995; 
Unwin and Capasso, 2000; Osborn et al., 2001; Paul and Ploth, 2001). 
 
The other mechanism of autoregulation which plays an important role in the 
control of renal hemodynamics is the tubuloglomerular feedback (TGF) mechanism that 
involves juxtaglomerular apparatus or JGA.  In fact, the TGF mechanism related to the 
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function of macula densa and JGA cells.  When there is any increase in RBF or GFR, 
there will be an increased delivery of NaCl to the macula densa cells in the distal 
nephron.  In response to this NaCl load the cells of macula densa mediate 
vasoconstriction of the afferent arterioles and that in turn causes an increase in the 
glomerular blood flow, decrease in the glomerular capillary pressure and finally 
normalization of GFR.  In contrast, when there is a decrease in the delivery of NaCl to 
the macula densa there will be a decrease in the glomerular blood flow.  This change in 
the glomerular blood flow leads to afferent arteriolar dilatation, increase in glomerular 
blood flow, increased glomerular capillary pressure and consequently the return of 
GFR towards normalization.  Adenosine has been identified as the possible mediator 
for TGF mechanism of autoregulation of renal hemodynamics.  This mechanism works 
more slowly than the myogenic mechanism.  However, it is critical for the maintenance 
of GFR in conditions that cause changes in intra-arteriolar pressure (Vander, 1995; 
Unwin and Capasso, 2000; Osborn et al., 2001; Paul and Ploth, 2001). 
  
Renin-angiotensin  
The renin-angiotensin system is an important regulator of intrarenal blood flow.  
The granular cells of juxtaglomerular apparatus secrete renin in response to several 
kinds of stimuli like hypovolemia, decreased cardiac contractility and renal artery 
stenosis.  The regulation of renin release is carried out by both intra- and extra-renal 
mechanisms.  The intra-renal mechanism comprises of afferent arteriolar baroreceptors 
and cells of macula densa while the extra-renal mechanism is the sympathetic nervous 
system.  Renin is released when renal baroreceptors cause constriction of the afferent 
arterioles in the face of decreased volume.  As far as the macula densa is concern, its 
cells stimulate renin release when they detect a decreased NaCl load being delivered 
to the distal tubules as a result of decreased RBF.  Angiotensin II is produced by the 
action of renin and angiotensin converting enzyme and is an active hormone which 
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causes vasoconstriction of both the afferent and efferent arterioles.  It decreases RBF 
through afferent arteriolar constriction.  However, simultaneous efferent arteriolar 
constriction produces resistance to fluid leaving the glomerular capillaries, which 
maintains glomerular hydrostatic pressure and GFR at normal despite a fall in RBF. 
The renin-angiotensin system is an intrinsic system triggered by local and systemic 
stimuli.  One of the important functions of this system is to maintain the perfusion of the 
vital organs like heart and brain in the face of hypovolemia and intrarenal 
vasoconstriction (Vander, 1995; Navar, 1998; Unwin and Capasso, 2000; Osborn et al., 
2001; Paul and Ploth, 2001). 
 
Eicosanoids 
The kidney produces a variety of eicosanoids locally in the nephron, interstitial 
cells and by the glomerular and vascular endothelium.  These eicosanoids include 
prostaglandins, thromboxanes, leukotrienes, and monooxygenase products.  Some of 
these eicosanoids are prostaglandins such as PGE1, PGE2 and prostacyclin like PGI2   
which act as vasodilators.  Whereas, other eicosanoids like thromboxane, leukotrienes, 
and some monooxygenase products are vasoconstrictors.  The vasodilatory 
prostaglandins play a major role in maintaining normal RBF in individuals with impaired 
renal function.  On the other hand, the physiological role of the vasoconstrictor 
prostaglandins is still unclear.  The best documented role of vasodilatory 
prostaglandins, however, is to counteract the vasoconstrictor effects of renal nerve and 
angiotensin.  These prostaglandins primarily act on the afferent arterioles and 
counteract the effects of angiotensin II and renal nerves.  In this way, these 
prostaglandins maintain the RBF despite systemic arteriolar vasoconstriction.  The 
prostaglandins also counteract the angiotensin II induced mesangial constriction and 
thereby preserve adequate surface area for filtration.  The vasodilatory prostaglandins 
also protect the kidneys by preventing them from extreme vasoconstriction in response 
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to angiotensin II or norepinephrine (Vander, 1995; Unwin and Capasso, 2000; Osborn 
et al., 2001; Paul and Ploth, 2001). 
.  
Kallikrein-Kinin 
These are inflammatory mediators produced in the kidney.  The bradykinin is 
formed in the kidney by the action of kallikrein secreted from the distal nephron cells.  
The physiological role of bradykinin in the control of renal hemodynamics is not fully 
understood, however, they are known as a vasodilator.  As far as the vasodilatory 
effect is concern, bradykinin stimulates the release of nitric oxide that leads to 
vasodilation.  It is also reported that they attenuate the renal ischemic effects of 
angiotensin II and norepinephrine (Osborn et al., 2001; Paul and Ploth, 2001). 
 
1.1.2.1.2 Extrinsic factors 
Several extrinsic factors are known to influence the renal hemodynamics.  
These substances or systems are mainly based outside the kidneys and can directly or 
indirectly initiate changes in RBF and GFR.  These extrinsic factors include 
sympathetic nervous system, angiotensin II, nitric oxide, endothelines, atrial natriuretic 
peptide, antidiuretic hormone (ADH) and dopamine.  Considering the importance of 
these factors in the regulation of RBF and GFR and also the context of the present 
study, here we will focus only on the effect of sympathetic nervous system and 
angiotensin II. 
 
Sympathetic nervous system 
The kidney is richly innervated with sympathetic nerves that enter the kidney at 
the hilum.  The nerve endings terminate in the smooth muscle cells of the afferent and 
efferent arterioles.  The afferent and efferent arteriolar vasoconstrictor responses are 
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produced by the direct activation of adrenergic receptors present in the cell surface of 
smooth muscle cells.  Indeed, strong activation of the renal sympathetic nerves result 
in substantial renal vasoconstriction mediated by α-adrenoceptors (mainly α1-
adrenoceptors) which leads to a decrease in RBF and GFR.  However, the 
simultaneous efferent arteriolar vasoconstriction helps to maintain the GFR by 
regulating the glomerular hydrostatic pressure (Vander, 1995; Unwin and Capasso, 
2000; Osborn et al., 2001; Paul and Ploth, 2001).  The α-adrenoceptors mediated 
increase in renal vascular resistance also represents a pathway for the α-
adrenoceptors that influences the renin secretion through baroreceptors dependent 
mechanism (Navar, 1998). 
. 
Angiotensin II  
Angiotensin II mediates multiple actions that act in concert to minimize renal 
blood fluid and sodium losses and to maintain arterial pressure (Navar, 1998).  In 
addition to its renal vascular effects, angiotensin II also stimulates the release of 
aldosterone that allows sodium and water reabsorption and increase the circulating 
volume.  These two effects combine for the maintenance of systemic pressure and 
perfusion of vital organs of the body.  Angiotensin II also stimulates the release of 
vasodilatory prostaglandins that attenuate the vasoconstrictive effects of angiotensin II 
in the kidneys.  Thus they play an important role in the maintenance of renal blood flow 
and glomerular filtration rate (Navar, 1998; Unwin and Capasso, 2000; Paul and Ploth, 
2001). 
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1.1.3 Innervations of the kidney 
 
1.1.3.1 Intrinsic innervations 
The kidney is innervated by intrinsic nerves and comprised of both efferent and 
afferent innervations.  The efferent intrinsic innervations of the kidney represents an 
expansion of the central nervous system that responds to peripheral and central 
afferent inputs.  A number of techniques have been used for the characterization of 
intrinsic innervations of the kidney; however, the electron and fluorescent microscopy 
have helped the most in the final characterization of intrinsic renal innervations.  The 
efferent sympathetic nerves reach all the segments of renal vasculature, entering at the 
hilus of the kidney.  These sympathetic innervations are distributed throughout the 
renal cortex and outer strip of the medulla having the highest density in the 
juxtamedullary region of the inner cortex and the lowest density in the tubules (Barajas 
et al., 1992).  These innervations follow the vasa recta into the outer medulla and 
simultaneously disappear with the disappearance of smooth muscle cells (Dinerstein et 
al., 1979). 
 
It is observed that an increased net renal venous outflow of norepinephrine 
derived from renal nerve terminals could result from direct stimulation of renal nerve.  
Chronic renal denervation could cause significant decrease in the renal norepinephrine 
concentration, hence, highlighting the importance of norepinephrine as a 
neurotransrnitter (Femandez-Repollet et al., 1985).  This notion also came under 
significant consideration from the increased norepinephrine concentration in the 
venous blood after stimulation of renal sympathetic nerve (Kopp et al., 1983).  
 
It has been proposed that low level of renal tubular innervation is inadequate to 
offer a full explanation of tubular effect of such innervations (Luff et al., 1992).  It has 
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also been proposed that how a neurotransmitter would reach the tubular epithelial cells 
could be explained by a substantial release of norepinephrine into the renal interstitium 
cells (Barajas et al., 1984).  
 
In a relatively recent report, it is proposed that functionally specific nerve fiber 
groups separately innervate tubules, juxtaglomerular granular cells and vessels and 
constituted the sympathetic renal nerves (DiBona, 2000). 
 
The foregoing reports may provide explanation on how the adrenergic renal 
nerves produce different effects on a variety of renal functional responses including 
tubular function as it allows for a different extent of renal nerve stimulation of some 
nerve fiber groups compared to others.  The sensory afferent renal nerves are localized 
in the corticornedullary connective tissues of the pelvic region and in the major vessels 
(Barajas et al., 1992).  These sensory afferent renal nerves project into ipsilateral 
dorsal root ganglia and the dorsal horn in the spinal cord.  These nerves are projected 
into medullar and hypothalamic sites that also receive afferent nerve fibers from the 
carotid sinus (DiBona, 1985). 
 
The role of the kidney in the homeostatic regulation of body fluid volume is 
ensured by peripheral afferent input provided by the sensory innervations.  Indeed, the 
renal sympathetic nerves are increasingly considered as being significant in the control 
of renal hemodynamics and tubular functions to maintain body’s fluid homeostasis, 
hence, blood pressure (DiBona and Kopp, 1997). 
 
Apart from sympathetic innervations, the intrinsic innervations of the kidney also 
consist of dopaminergic and parasympathetic nerves.  The presence of dopaminergic 
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nerves in the kidney is a compelling issue (DiBona, 1990).  However, dopamine has 
been found to be present in all adrenergic nerve terminals as a precursor of 
noradrenaline. Dopamine is released from the adrenergic sympathetic postganglionic 
nerve terminals together with noradrenaline (DiBona and Kopp, 1997). 
 
In kidney, the parasympathetic innervation is presumed to be the part of the 
abdominal visceral distribution of the vagus nerve.  Acetylcholine is secreted by the 
postganglionic parasympathetic nerve terminals and their existence has been inferred 
by the use of histochemical staining technique for acetylcholinesterase.  However, 
there is no conclusive evidence in favor of independent cholinergic innervation in 
kidney.  In studies with retrograde tracing for possible efferent parasympathetic 
innervation in rat showed that the rat kidney did not have functional cholinergic 
innervation (DiBona and Kopp, 1997).  
 
1.1.3.2 Extrinsic innervations 
Several different labeling techniques have contributed in the understanding of 
the extrinsic innervations of the kidney.  In this effort, particularly in the rat, 
acetylcholinesterase was utilized in the tracing of efferent and afferent nerve fibers 
between the kidney and also other nerves like the celiac plexus, splanchnic nerves, the 
lumbar splanchnic nerves and the inter-mesenteric nerve plexus (Drukker et al., 1987). 
Indeed, the use of different labeling techniques allowed to trace into the central 
nervous system (Vollanueva et al., 1991; Barajas et al., 1992).  The regulatory centers 
of the renal sympathetic activity include the rostral ventrolateral medulla (RVLM), A5 
area, caudal raphe nuclei of the sympathetic premotor nuclei and paraventricular 
nucleus of the hypothalamus (Ding et al., 1993).  Among these the rostral ventrolateral 
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medulla is the most important for the cardiovascular reflexes and also in the generation 
of sympathetic tone (Dampney, 1994). 
 
Anatomically, the extrinsic innervation of the kidney originates from the 12th 
thoracic and 1st lumbar segments, passes through the celiac ganglia and its 
subdivisions, the lumbar splanchic nerves, the superior mesenteric ganglion and along 
the renal artery towards the kidneys (Lumley et al., 1996).  The celiac plexus comprises 
of the aorticorenal ganglion, celiac ganglion and major splanchnic nerves.  The thoracic 
splanchnic nerves, lumber splanchnic nerves and vagus nerves partly form the celiac 
ganglion.  The suprarenal ganglion gives off many branches towards the adrenal gland 
and some of which pass along the adrenal artery to the perivascular neural bundles 
around the renal artery and entering into the hilus of the kidney, while other branches 
enter into the outer side of the renal hilar region of the kidney (Lumley et al., 1996; 
Dworkin et al., 2000). 
 
1.2 Sympathetic control of renal hemodynamics 
It is well known that the sympathetic nervous system plays a pivotal role in the 
regulation of renal hemodynamics.  The kidneys receive a rich supply of sympathetic 
nerves and it is perceived that the renal sympathetic nerve activity plays an important 
role in the regulation of renin release and tubular sodium reabsorption (Yoshimoto et al. 
2004).  There is large body of evidence indicating the involvement of renal adrenergic 
nerves in the regulation of renal vascular resistance (Navar, 1998; Salomonsson and 
Arendshorst, 2001).  In renal vasculature, the catecholamines released from nerve 
terminals and of humoral origin exert their effect by the stimulation of adrenoceptors 
present in the cell surface of smooth muscle cells in order to produce changes in the 
cytosolic calcium concentration and subsequent contraction.  In this process, the 
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binding of ligands to the cell surface adrenoceptors lead to the binding of calcium ion 
with calmodulin followed by a change in calmodulin structure.  This change in the 
structure of calmodulin then cause activation of myosin light chain kinase that in turn 
cause increased tone of smooth muscle cells (Walsh, 1994).  
 
It is observed that an increase in the sympathetic nervous system activity of the 
kidney causes direct increase in renal vascular resistance.  Marked renal vascular 
constriction mediated by α -adrenoceptors can be caused by strong activation of renal 
nerve that leads to decreased renal blood flow and glomerular filtration rate, increased 
renin release and increased sodium and water reabsorption.  Increased renal 
adrenergic nerve activity can be a part of overall sympathetic response or may be more 
selective.  Decrease in renal nerve activity can be induced reflexively through 
cardiopulmonary receptors and renorenal reflexes (Navar, 1998; Salomonsson and 
Arendshorst, 2001).  It is observed that low-level of renal nerve stimulation can cause 
activation of β-adrenoceptors which in turns cause renin release by direct action on the 
juxtaglomerular apparatus cells.  Moderate level of renal nerve stimulation causes 
comparable increase in afferent and efferent arteriolar resistance and leads to a slightly 
higher drop in renal blood flow than glomerular filtration rate.  However, higher level of 
renal nerve stimulation causes strong periglomerular resistance that leads to a major 
drop in the renal blood flow.  These observations, indeed, showed an important role of 
the sympathetic control of the renal hemodynamics (Navar, 1998).  
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1.3 Role of kidney in hypertension – special reference to the role of renal 
impairment 
The kidney and hypertension were linked decades before the 
sphygmomanometer had been invented.  Richard Bright, a remarkably astute observer 
of autopsies, noted in 1836 (Bright, 1836) that patients with the disease now known as 
chronic nephritis also had hypertrophied hearts.  Based on his remarkable 
observations, he postulated that in these patients the quality of the blood was altered in 
some manner that required heart to work harder in order to force it through the blood 
vessels.  In 1889 after the invention of sphygmomanometer it soon became clear that 
the quality of the blood Bright was seeking was blood pressure (Rocci, 1896).  In 
relation to these observations, few years later two investigators from Denmark working 
on the connection between kidney and hypertension shed light on renin as a long-
lasting pressor effector substance present in the blood stream and localized in the 
renal cortex and further strengthened the view that kidney, indeed, played a role in the 
genesis of hypertension (Ritz et al., 2003). 
 
Kidney is considered as a vital organ of the body that plays a dominant role in the 
maintenance of volume in the body fluid spaces through its influence on sodium and 
water excretion.  Thus, it is inevitable that kidney must be involved in the 
pathophysiology of hypertension.  This is because of the fact that the renal perfusion 
pressure is a major determinant of sodium and water excretion and as mentioned by 
Guyton et al. (1974) that hypertension could not be stated unless the relationship 
between renal perfusion pressure and its output of sodium and water had been altered. 
  
Indeed, in his original hypothesis Guyton (Guyton et al.,1974) had proposed that 
a disturbance of the blood pressure-natriuresis relationship is responsible for the 
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elevated blood pressure observed in the case of impaired renal function.  This 
statement does not, however, indicates that hypertension is a renal disease, rather 
implied that the kidney and more precisely the pressure–natriuresis relationship is the 
sine qua non condition for the development of hypertension (Ritz et al., 2003). 
 
As we have discussed in the foregoing paragraphs, the influence of the kidney on 
hypertension is, indeed, strong as was first pointed out in the work of Bright and others. 
In the recent decades, the use of kidney transplantation studies strongly supported the 
notion that kidney was involved in the genesis of hypertension.  It was observed that 
when a person with end-stage renal diseases received a kidney from a normal donor, 
the elevated blood pressure often comes to normal, hence strengthening the testimony 
to the antihypertensive action of a normal kidney and therefore the role of the kidney 
and/or diseased kidney. 
 
Several experiments of renal transplantation in rats with genetic hypertension and 
normal animals showed that “blood pressure goes with kidney”.  It has been observed 
that transplantation of the kidney from a spontaneously hypertensive donor rat causes 
a progressive elevation of blood pressure in a normotensive recipient animal which had 
been immunologically manipulated to prevent a possible rejection reaction (Bianchi et 
al., 1974; Rettig et al., 1990; Patschan et al., 1997).  These results indicate that the 
kidney somehow carries the messages of blood pressure and that the kidney can 
modulate the level of blood pressure within the body.  The same phenomenon has 
been observed in human as recipients of renal graft from hypertensive donors are 
found to require more hypertensive medication.  In all of these reports it was assumed 
that the hypertensive donors might have damaged kidney caused by the persistent 
hypertension or at least they had impaired renal function, a common feature of long-
lasted genetic hypertension (Curtis et al., 1983).  
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Considering these observations several studies have been carried out and it has 
been reported that kidney could be involved in the genesis of hypertension by virtue of 
its two obvious endocrine cell types.  One of these is the juxtaglomerular cell that 
secretes renin.  Renin causes the elaboration of angiotensin I (ANG I) which converted 
into angiotensin II (ANG II), one of the most potent pressor agents known so far.  ANG 
II constricts arterioles directly and causes the adrenergic nerves to release more 
norepinephrine.  It acts on specific receptors in the brain to cause an increased 
sympathetic activity.  It enhances aldosterone secretion from adrenal zona glomerulasa 
and also could act on the renal tubules to cause retention of sodium.  Another 
endocrine cell present in the kidney having vasoactive properties is the interistitial cell 
which is present in the inner medulla of the kidney of all mammals.  These cells secrete 
prostaglandin and neutral lipid and most importantly they have ANG II receptors in the 
cell wall.  These cells are believed to be involved in the regulation of blood pressure by 
the kidney.  The kidney can also control blood pressure by way of sodium excretion.  
One good example of this event could be someone with renal parenchymal diseases 
where one-fourth of the nephron still remains intact.  Such patients come into sodium 
balance with a high level of sodium in the body and very apt to have hypertension, 
contrasting with someone possessing good kidney with no difficulties in sodium 
excretion.  Thus, the capability of the body to excrete sodium is another means by 
which kidney can be related in the genesis of hypertension (Tobin, 1983). 
 
In relation to the pressure-natriuresis hypothesis mentioned in the forgoing 
paragraphs, it has also been hypothesized that the baroreceptors in the kidney, which 
control the release and secretion of renin, are exposed to an inhomogeneous spectrum 
of perfusion pressure caused by the luminal narrowing of some of the preglomerular 
vessels (Navar et al., 2002).  As a consequence, a proportion of the glomeruli senses 
inappropriately low perfusion pressure and secretes renin independent of the systemic 
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blood pressure.  Indeed, it has been shown that in patients with renal diseases, the 
plasma renin activity is elevated and is not adequately suppressed when blood 
pressure is increased.  It is also reported that the local renin-angiotensin system is 
activated if renal damage has occurred (Kuczera et al., 1991). 
 
In recent years, based on studies carried out in animals and in human it has been 
reported that intrarenal chemoreceptors and baroreceptors are stimulated in renal 
diseases.  Such stimulatory signals are transmitted through the medulla to the 
hypothalamus causing increased norepinephrine turnover in the hypothalamus and 
efferent sympathetic nerve traffic.  It has been seen that increased sympathetic nerve 
traffic as documented by microneurography of the sural nerve, was no longer 
demonstrable in dialyzed patients after they had undergone bi-nephrectomy.  Similarly, 
after renal transplantation, the sympathetic nerve activity remains high, but is 
decreased once the non-functional kidney of the patients has been removed.  
However, it is still unknown to which extent such activation of the sympathetic nervous 
system by the kidneys contribute in the pathogenesis of hypertension (Converse et al., 
1992; Hausberg et al., 2002). 
 
Another pathway through which the renal abnormalities can interfere with the 
blood pressure control is increased oxidative stress and endothelial cell dysfunction.  In 
various renal damage models, it has been observed that hypertension can be 
ameliorated by the administration of tempol, a cell membrane permeable agonist of 
superoxide dismutase.  It has been postulated that increased oxidative stress 
scavenges nitric oxide and diminish the bioavailability of this endogenous vasodilator 
(Vaziri et al., 2003) and hence causes vasoconstriction leading to the elevated blood 
pressure. 
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1.4 Receptors 
Receptors are defined as various cell membrane recognition sites with which 
various drugs, hormones and neurotransmitters interact to exert discrete biological 
effects (Williams et al., 1995). 
 
In the early 19th century the concept of receptor first evolved from a historical 
observation of the extraordinary potency and specificity of some drugs that mimicked 
biological responses.  Drugs able to mimic a particular type of biological response were 
known as agonist while those that inhibited such responses were named antagonists.  
Later, this phenomenon was further clarified in terms of quantitative characteristic of 
competitive antagonism between agonists and antagonists in combining with specific 
receptors in intact cell preparation.  In light of these observations, the concept of 
receptors has been established by the isolation of molecules that truly fit all the criteria 
of being receptors (Cooper et al., 1996).  To date many receptors have been identified 
for many neurotransmitters as well as for other biomolecules like angiotensin, 
bradykinin, opioid peptides, histamines and so on (Cooper et al., 1996).  Moreover, 
multiple rather than single receptors have been shown for some molecules.  For 
instance, the biogenic amines, viz. acetylcholine, GABA, histamine, opiates, the amino 
acid transmitters and others have multiple receptors.  
 
Receptors study is considered one of the most intensively investigated areas of 
research in vascular pharmacology and neuroscience which has led to the 
development of new drugs based on the research of adrenergic, dopaminergic, 
muscarinic, serotoninergic and histaminergic receptors.  Recent advances in molecular 
biological techniques have further enhanced this progress by enabling scientists to 
identify several receptor subtypes, their mRNAs, relative abundance, tissue distribution 
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and so on and hence led to the development of drugs highly specific for a certain 
subtype (Cooper et al., 1996). 
 
1.4.1 Adrenoceptors 
The adrenoceptors are membrane receptors located in both neuronal and non-
neuronal tissues.  These heterogeneous groups of receptors constitute a subfamily of 
the seven transmembrane domains/G-protein couple receptors involved in mediating 
central and peripheral actions of endogenous catecholamines, adrenaline and 
noradrenaline.  Noradrenaline is released from the noradrenergic post-gangllionic 
nerve terminals and secreted from the adrenal medulla.  These catecholamines are 
involved in several important function including cardiovascular, respiratory and 
neuronal functions.  They are also involved in digestion, energy metabolism and 
endocrine functions.  The adrenoceptors through which they operate thus constitute 
immense importance as therapeutic targets in the treatment of a range of ailments 
including cardiovascular diseases, asthma, prostatic hypertrophy, obesity etc. 
(Docherty, 1998; Guimarães and Moura, 2001). 
 
1.4.1.1 Classification of adrenoceptors 
Different studies started since early eighteenth century have shaped our 
present knowledge about adrenoceptors and have facilitated their classification.  The 
first step of any systematical approach in the discovery of the adrenoceptor was made 
in 1905 from the observations of Dale (Dale, 1905).  He observed that the pressor 
effect of adrenaline was reversed by ergotoxine into a depressor effect.  In 1937, 
Cannon and Rosenblueth put forward a hypothesis, which initiated the idea of 
classification of adrenoceptors.  They put forward their hypothesis based on the 
existence of two neurotransmitters or endogenous mediators in the organism to explain 
